Regulatory Affairs Part II: The CTD/NDA Phase

5 - 7 May 2008, Baltimore, United States


Introduction
This course will offer insight into the regulatory background of the NDA, outline how to prepare an NDA in CTD format, and review post-approval activities. The course will focus on drug and well-characterized biological products and not the regulatory process for devices, generic products or traditional biologics.

COURSE HIGHLIGHTS
•Overview, and roles and responsibilities of FDA
•NDA in CTD format
•Regulatory compliance and FDA inspections
•Post approval regulatory requirements for NDAs
•Regulatory requirements for prescription drug labeling
•Review of prescription drug/biologics advertising and promotional labeling.
Venue
Sheraton Inner Harbor Hotel

Sheraton Inner Harbor Hotel, 300 S Charles Street, Baltimore, 21201, United States

Organised by
Drug Information Association
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*